tiprankstipranks
Trending News
More News >
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Financial Statements

Compare
695 Followers

Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently $2.92B. The company's EPS TTM is $-0.16; its P/E ratio is -13.81; Nuvation Bio is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 7.87M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 795.00K$ 0.00$ 0.00$ 0.00$ -103.00K
Operating Income$ -592.63M$ -99.82M$ -119.73M$ -93.32M$ -43.55M
EBITDA$ -566.91M$ -75.58M$ -119.53M$ -93.13M$ -41.56M
Net Income$ -567.94M$ -75.80M$ -104.20M$ -86.85M$ -41.66M
Balance Sheet
Cash & Short-Term Investments$ 502.69M$ 611.21M$ 661.01M$ 765.39M$ 215.75M
Total Assets$ 540.63M$ 621.48M$ 672.14M$ 776.15M$ 221.79M
Total Debt$ 8.91M$ 4.01M$ 4.26M$ 3.06M$ 0.00
Net Debt$ -26.81M$ -38.64M$ -96.84M$ -129.37M$ -29.75M
Total Liabilities$ 76.84M$ 16.36M$ 17.07M$ 30.15M$ 6.71M
Stockholders' Equity$ 463.79M$ 605.12M$ 655.08M$ 746.00M$ 215.08M
Cash Flow
Free Cash Flow$ -130.57M$ -68.07M$ -96.48M$ -68.47M$ -36.67M
Operating Cash Flow$ -130.41M$ -68.00M$ -96.11M$ -68.19M$ -36.53M
Investing Cash Flow$ 122.70M$ 8.92M$ 63.46M$ -454.67M$ -70.32M
Financing Cash Flow$ 331.00K$ 628.00K$ 1.33M$ 625.53M$ 133.13M
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS